Worldwide HealthcareWWH:LSE

1,930
30.00 / 1.58%
49.41k
52.33%
0.501
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of May 27 2015 18:06 BST.

Total returns on £1000

Fund / BenchmarkChange
PriceWorldwide Healthcare (Ordinary Share)+51.42 %
Worldwide Healthcare (Ordinary Share)+54.50 %
Morningstar's BenchmarkFTSE World+16.30 %
As of May 26 2015.

Worldwide Healthcare summary

Shares outstanding47.76m
Market cap909.90m GBP
Total assets1.11bn GBP
Total expense ratio1.01%
Day high1,938
Day low1,898
Previous close1,900
Average volume50.91k
YTD Change+12.63 %
Beta0.5010%
Diluted NAV (est)2,082.84
Diluted NAV (last pub)2,053.6
Premium/Discount-8.78 %
Gearing+112.00 %
52-week range
Today
1,260
May 27 2014
1,992.4
Mar 20 2015

As of last trade WWH:LSE traded at 1,930, 3.13 % below its 52-week high of 1,992.4, set on Mar 20, 2015.

Data delayed at least 15 minutes, as of May 27 2015 18:06 BST.

Profile

Management group(s)OrbiMed Capital LLC
AIC sectorSector Specialist: Biotechnology/Life Sciences
ISINGB0003385308
Launch date28 Apr 1995
Share typeOrdinary Share
StructureConventional
Base currencyGBP

Objective

To invest worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.

Management & contract fees

The Investment Manager, receives a periodic fee equal to 0.65% p.a. of the Company's net asset value. The performance fee amounts to 16.5% of any out-performance of the NAV over the benchmark index.

Dividend

Div yield0.81871
Div ex-date04 Dec 2014
Div pay-date09 Jan 2015

Managed by

Sven Borho Start : 01 Feb 2013
Samuel. D Isaly Start : 28 Apr 1995
Data delayed at least 15 minutes, as of May 27 2015 18:06 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.